The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
The Gavi Board today approved the Vaccine Alliance's strategy for the five-year period running from 2026 to 2030
DCGI has also granted permission to manufacture and market FDF of Cefepime and Enmetazobactam as a dry powder injectable
Empowering Research, Enhancing Proficiency is the theme of this year’s Homoeopathic Symposium
With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
Emphasizes the need for a collective effort on bolstering resilience across economies, societies, healthcare systems, education systems and infrastructure
Extraintestinal pathogenic E. coli (ExPEC) has been identified as the leading bacterial cause of sepsis
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
Subscribe To Our Newsletter & Stay Updated
